FDA.reportPublic FDA data

linvoseltamab-gcpt 5 MG per 2.5 ML Injection

RxCUI
2719494
RxNorm name
linvoseltamab-gcpt 5 MG per 2.5 ML Injection
Display name
linvoseltamab-gcpt 5 MG per 2.5 ML Injection
Full name
linvoseltamab-gcpt 5 MG per 2.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761400Lynozyficlinvoseltamab-gcpt351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e9fd0739-1b3f-4b8b-824a-1f0a902384d3linvoseltamab-gcpt 5 MG in 2.5 ML Injection [PSN] · 2.5 ML linvoseltamab-gcpt 2 MG/ML Injection [SCD] · linvoseltamab-gcpt 5 MG per 2.5 ML Injection [SY]36These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702